TEMTSIN-KRAYZ, Galia,GLOZMAN, Sabina,KAZHDAN, Pavel
申请号：
EP16859209
公开号：
EP3368084A4
申请日:
2016.10.28
申请国别(地区):
EP
年份:
2019
代理人:
摘要：
A pharmaceutical composition is provided for transmucosal administration of an active lipophilic compound through the oral mucosa comprising a lipophilic active compound, a polymeric matrix formed by two or more water-soluble polymers and a rapid dissolution agent. At least one of the water-soluble polymers is an amphiphilic polymer and at least one is either a hydrophilic polymer or an amphiphilic polymer with a hydrophobic-hydrophilic balance different from the first amphiphilic polymer. In addition, the polymeric matrix is not crosslinked and no covalent interaction occurs between the two or more polymers and between the polymers and the lipophilic active compound, which is interwoven with the aforesaid polymeric matrix.
